Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.

Kim SH, Lee CH, Kim BH, Kim WB, Yeom SK, Kim KA, Park CM.

J Comput Assist Tomogr. 2012 Nov-Dec;36(6):704-9. doi: 10.1097/RCT.0b013e3182706562.

PMID:
23192208
2.

Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.

Leyendecker JR, Gakhal M, Elsayes KM, McDermott R, Narra VR, Brown JJ.

J Comput Assist Tomogr. 2008 Mar-Apr;32(2):178-84. doi: 10.1097/RCT.0b013e31806bef8e.

PMID:
18379298
3.

"Nondefect" of arterial enhancing rim on hepatobiliary phase in 3.0-T gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging: distinguishing hepatic abscess from metastasis.

Choi SH, Lee CH, Kim BH, Lee J, Choi JW, Park YS, Kim KA, Park CM.

J Comput Assist Tomogr. 2013 Nov-Dec;37(6):849-55. doi: 10.1097/RCT.10.1097/RCT.0b013e318297211a.

PMID:
24270105
4.

Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.

Kang Y, Lee JM, Kim SH, Han JK, Choi BI.

Radiology. 2012 Sep;264(3):751-60. doi: 10.1148/radiol.12112308. Epub 2012 Jul 12.

PMID:
22798225
5.

T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.

Tamada T, Ito K, Yoshida K, Sone T, Murakami K, Kanki A, Watanabe S, Higashi H, Yamashita T.

J Comput Assist Tomogr. 2010 Mar-Apr;34(2):182-6. doi: 10.1097/RCT.0b013e3181bc961b.

PMID:
20351500
6.

Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the "target sign" a common finding?

Ha S, Lee CH, Kim BH, Park YS, Lee J, Choi JW, Kim KA, Park CM.

Magn Reson Imaging. 2012 Oct;30(8):1083-90. doi: 10.1016/j.mri.2012.03.007. Epub 2012 May 11. Review.

PMID:
22578929
7.

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.

Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T.

J Gastroenterol. 2012 Sep;47(9):1036-47. doi: 10.1007/s00535-012-0571-6. Epub 2012 Apr 17.

PMID:
22526270
8.

Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.

Hwang J, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Rhim HC.

J Magn Reson Imaging. 2012 Oct;36(4):881-9. doi: 10.1002/jmri.23728. Epub 2012 Jun 21.

PMID:
22730271
9.

Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T.

Radiology. 2010 Jul;256(1):151-8. doi: 10.1148/radiol.10091885.

PMID:
20574092
10.

Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.

Chong YS, Kim YK, Lee MW, Kim SH, Lee WJ, Rhim HC, Lee SJ.

Clin Radiol. 2012 Aug;67(8):766-73. doi: 10.1016/j.crad.2012.01.004. Epub 2012 Mar 15.

PMID:
22425613
11.
12.

Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.

Péporté AR, Sommer WH, Nikolaou K, Reiser MF, Zech CJ.

Eur J Radiol. 2013 Mar;82(3):e101-6. doi: 10.1016/j.ejrad.2012.10.010. Epub 2012 Nov 16.

PMID:
23159401
13.

HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.

Kanata N, Yoshikawa T, Ohno Y, Kanda T, Uchida K, Izaki K, Fukumoto T, Ku Y, Itoh T, Kitajima K, Takahashi S, Sugimura K.

Magn Reson Imaging. 2013 Jan;31(1):17-22. doi: 10.1016/j.mri.2012.06.012. Epub 2012 Aug 13.

PMID:
22898685
14.

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.

Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.

Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.

PMID:
20057319
15.

Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.

Tajima T, Takao H, Akai H, Kiryu S, Imamura H, Watanabe Y, Shibahara J, Kokudo N, Akahane M, Ohtomo K.

J Comput Assist Tomogr. 2010 May-Jun;34(3):362-6. doi: 10.1097/RCT.0b013e3181cd3304.

PMID:
20498536
16.

Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.

Park HJ, Kim YK, Park MJ, Lee WJ.

Abdom Imaging. 2013 Aug;38(4):793-801. doi: 10.1007/s00261-012-9943-x.

PMID:
22829097
17.

Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

Matsuda M, Tsuda T, Yoshioka S, Murata S, Tanaka H, Hirooka M, Hiasa Y, Mochizuki T.

Jpn J Radiol. 2014 Jul;32(7):405-13. doi: 10.1007/s11604-014-0323-z. Epub 2014 May 24.

PMID:
24854900
18.

Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.

Kunishi Y, Numata K, Morimoto M, Okada M, Kaneko T, Maeda S, Tanaka K.

AJR Am J Roentgenol. 2012 Jan;198(1):106-14. doi: 10.2214/AJR.10.6039.

PMID:
22194485
19.

Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.

Kanki A, Tamada T, Higaki A, Noda Y, Tanimoto D, Sato T, Higashi H, Ito K.

Magn Reson Imaging. 2012 Apr;30(3):356-60. doi: 10.1016/j.mri.2011.11.002. Epub 2012 Jan 5.

PMID:
22227353
20.

Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation.

Fujiwara H, Sekine S, Onaya H, Shimada K, Mikata R, Arai Y.

Jpn J Radiol. 2011 Dec;29(10):739-43. doi: 10.1007/s11604-011-0624-4. Epub 2011 Oct 19.

PMID:
22009428
Items per page

Supplemental Content

Write to the Help Desk